Optimalisation of tablet formula from chlorophyll of Sauropus androgynus (L.) Merr. leaves using simplex lattice design (SLD)
Context: Sauropus androgynus (L) Merr, known as a sweet leaf, contains chlorophyll, potentially an antioxidant. The selection of appropriate excipient composition affects the physical properties and therapy effectiveness of tablets from S. androgynus chlorophyll. Aims: To determine the composition o...
Saved in:
Published in | Journal of pharmacy & pharmacognosy research Vol. 13; no. 2; pp. 591 - 596 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
01.03.2025
|
Online Access | Get full text |
Cover
Loading…
Abstract | Context: Sauropus androgynus (L) Merr, known as a sweet leaf, contains chlorophyll, potentially an antioxidant. The selection of appropriate excipient composition affects the physical properties and therapy effectiveness of tablets from S. androgynus chlorophyll. Aims: To determine the composition of the optimum excipient with variations in magnesium stearate and microcrystalline cellulose (MCC) concentrations and evaluate the physical properties of the tablet formula of chlorophyll S. androgynus leaves. Methods: S. androgynus chlorophyll tablets were formulated using the direct compression method. The dose of S. androgynus chlorophyll was converted from the effective dose of antianaemia in rats of 0.016 mg/200 g BW to the human dose of 0.896 mg. A simplex lattice design (SLD) was adopted to optimize the eight formulations. Results: SLD can be used to optimize the concentrations of magnesium stearate and MCC in the tablet formulation from S. androgynus chlorophyll. The 5% magnesium stearate formula and 20% MCC had the highest uniformity and disintegration time. The relative concentration of magnesium stearate and MCC influence the thickness, weight, hardness, friability, and disintegration time of the tablets produced. Conclusions: The 5% magnesium stearate formula and 20% MCC had the shortest disintegration time and can be considered the optimum formula for tablets from S. androgynus chlorophyll. Further study on the beneficial and toxic effects of tablets from S. androgynus chlorophyll would be very beneficial in preventing iron deficiency anaemia. |
---|---|
AbstractList | Context: Sauropus androgynus (L) Merr, known as a sweet leaf, contains chlorophyll, potentially an antioxidant. The selection of appropriate excipient composition affects the physical properties and therapy effectiveness of tablets from S. androgynus chlorophyll. Aims: To determine the composition of the optimum excipient with variations in magnesium stearate and microcrystalline cellulose (MCC) concentrations and evaluate the physical properties of the tablet formula of chlorophyll S. androgynus leaves. Methods: S. androgynus chlorophyll tablets were formulated using the direct compression method. The dose of S. androgynus chlorophyll was converted from the effective dose of antianaemia in rats of 0.016 mg/200 g BW to the human dose of 0.896 mg. A simplex lattice design (SLD) was adopted to optimize the eight formulations. Results: SLD can be used to optimize the concentrations of magnesium stearate and MCC in the tablet formulation from S. androgynus chlorophyll. The 5% magnesium stearate formula and 20% MCC had the highest uniformity and disintegration time. The relative concentration of magnesium stearate and MCC influence the thickness, weight, hardness, friability, and disintegration time of the tablets produced. Conclusions: The 5% magnesium stearate formula and 20% MCC had the shortest disintegration time and can be considered the optimum formula for tablets from S. androgynus chlorophyll. Further study on the beneficial and toxic effects of tablets from S. androgynus chlorophyll would be very beneficial in preventing iron deficiency anaemia. |
Author | Fasitasari, Minidian Suparmi, Suparmi Lestanu, Lucky April Latifah, Fadzil Rustanti, Ninik |
Author_xml | – sequence: 1 givenname: Suparmi orcidid: 0000-0001-7914-870X surname: Suparmi fullname: Suparmi, Suparmi – sequence: 2 givenname: Fadzil orcidid: 0009-0004-6041-1706 surname: Latifah fullname: Latifah, Fadzil – sequence: 3 givenname: Lucky April surname: Lestanu fullname: Lestanu, Lucky April – sequence: 4 givenname: Minidian orcidid: 0000-0003-4797-4745 surname: Fasitasari fullname: Fasitasari, Minidian – sequence: 5 givenname: Ninik orcidid: 0000-0002-8308-8057 surname: Rustanti fullname: Rustanti, Ninik |
BookMark | eNqdjz1PwzAYhC1UJAr0N_CO7VBjO0mjzHyIoYih7JZJ7dSVY1t-HUQG_jsBFYmZ6e6kO-meSzLzwWtCbjij1aZsmttjjEmjKKngopC8oIJWDT8jc1bzZl2Kis3--AuyQDwyxni9KYuaz8nnS8y2V86iyjZ4CAayenM6gwmpH5wCk0IP7cGFFOJhdO67slPDlAYE5fcpdKOf7HJLV_CsU6LgtHrXCANa3wHaPjr9AU7lbFsNe42287Dcbe9X1-TcKId6cdIrUj8-vN49rdsUEJM2MqbpXRolZ_IHWP4CyxOwFHICLv6__AKhm2bM |
ContentType | Journal Article |
DBID | AAYXX CITATION |
DOI | 10.56499/jppres24.2123_13.2.591 |
DatabaseName | CrossRef |
DatabaseTitle | CrossRef |
DatabaseTitleList | CrossRef |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Pharmacy, Therapeutics, & Pharmacology |
EISSN | 0719-4250 |
EndPage | 596 |
ExternalDocumentID | 10_56499_jppres24_2123_13_2_591 |
GroupedDBID | 5VS AAYXX ADBBV ALMA_UNASSIGNED_HOLDINGS BCNDV CITATION GROUPED_DOAJ GX1 HH5 KQ8 M~E OK1 |
ID | FETCH-crossref_primary_10_56499_jppres24_2123_13_2_5913 |
ISSN | 0719-4250 |
IngestDate | Wed Nov 13 12:40:15 EST 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 2 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-crossref_primary_10_56499_jppres24_2123_13_2_5913 |
ORCID | 0000-0003-4797-4745 0000-0002-8308-8057 0000-0001-7914-870X 0009-0004-6041-1706 |
ParticipantIDs | crossref_primary_10_56499_jppres24_2123_13_2_591 |
PublicationCentury | 2000 |
PublicationDate | 2025-3-1 |
PublicationDateYYYYMMDD | 2025-03-01 |
PublicationDate_xml | – month: 03 year: 2025 text: 2025-3-1 day: 01 |
PublicationDecade | 2020 |
PublicationTitle | Journal of pharmacy & pharmacognosy research |
PublicationYear | 2025 |
SSID | ssj0001764371 |
Score | 4.688427 |
Snippet | Context: Sauropus androgynus (L) Merr, known as a sweet leaf, contains chlorophyll, potentially an antioxidant. The selection of appropriate excipient... |
SourceID | crossref |
SourceType | Aggregation Database |
StartPage | 591 |
Title | Optimalisation of tablet formula from chlorophyll of Sauropus androgynus (L.) Merr. leaves using simplex lattice design (SLD) |
Volume | 13 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEF5F5cIFQQviWc0BVa1Sm_ixdnpEQFShBColSL1Za3dNLYIdObZEKvGD-RfM7K4fLZEgXCxnnR15PZ9nZ8ffzDL22pOh9JIRtwIvlJbPXbSD3lhaY8ETLtE_T1Sd7dmn4PyL__GSXw4Gv3qspbqK7eRma17J_2gV21CvlCW7g2ZbodiA56hfPKKG8fhPOv6M7_t3qmDY-n0VZUJVKiWxXgqdPJJc45q8wMe5VH7nXFAAvla1mcvi6yavVeB1SglXw5ksS5u2kqBitLWKI6wzKiD8Y7gUFRHlhleK80Fd5tP3TSDhT_d2pWtia0KO-VEQq28zNAWG2kD0vF7h5UyThNRpSxPCgaVCRX4m4uqmo4NMJXm1tYoq1Mm3DXrTZXd1ItZZJdZCZ9HPsjxr3wIT4HB5x_AydjB0ziw0LfrzjdzS1hhyrwdYt2eVud4QzEzwXG-he3fu4AEu_mjyWBED2fVtmtQjx7Ndu-3fr9Z9ZxZtuY24qlKiokZQZARFbsSpzsI9F21i0Fv9q3BgSF9Q1f6OzdA0G1HJerP9pnq-VM8pWjxkD4y64a2G5iM2kPk-O7owqj-FRZfdtz6FI7joCqVvDtjP2_iFIgWNXzD4BcIv9PBLf2nwCx1-4Xhqn4DCLmjsgsIuGOyCwS5o7MIxIvfkMQsnHxbvzq1mcNFKV16J_vJsvSdsLy9y-ZRBnLoCfW8ndHzpp14Qp07oiTNajstRMo6fsdGu0p_v3uUFu98h-iXbq8pavkIntooPlfp_A7YHo8Y |
link.rule.ids | 315,783,787,867,27936,27937 |
linkProvider | Directory of Open Access Journals |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Optimalisation+of+tablet+formula+from+chlorophyll+of+Sauropus+androgynus+%28L.%29+Merr.+leaves+using+simplex+lattice+design+%28SLD%29&rft.jtitle=Journal+of+pharmacy+%26+pharmacognosy+research&rft.au=Suparmi%2C+Suparmi&rft.au=Latifah%2C+Fadzil&rft.au=Lestanu%2C+Lucky+April&rft.au=Fasitasari%2C+Minidian&rft.date=2025-03-01&rft.issn=0719-4250&rft.eissn=0719-4250&rft.volume=13&rft.issue=2&rft.spage=591&rft.epage=596&rft_id=info:doi/10.56499%2Fjppres24.2123_13.2.591&rft.externalDBID=n%2Fa&rft.externalDocID=10_56499_jppres24_2123_13_2_591 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0719-4250&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0719-4250&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0719-4250&client=summon |